Nothing seems to bother Zomedica (NYSE:ZOM)

Earnings results for Zomedica (NYSE:ZOM)

Zomedica Corp. is estimated to report earnings on 11/10/2020. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $0. The reported EPS for the same quarter last year was $-0.03.

Zomedica last posted its earnings data on August 10th, 2020. The reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by $0.01. Zomedica has generated ($0.19) earnings per share over the last year. Zomedica has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 10th, 2020 based off prior year’s report dates.

Analyst Opinion on Zomedica (NYSE:ZOM)

1 Wall Street analysts have issued ratings and price targets for Zomedica in the last 12 months. Their average twelve-month price target is $0.50, predicting that the stock has a possible upside of 611.24%. The high price target for ZOM is $0.50 and the low price target for ZOM is $0.50. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”

Zomedica has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $0.50, Zomedica has a forecasted upside of 611.2% from its current price of $0.07. Zomedica has only been the subject of 1 research reports in the past 90 days.

Dividend Strength: Zomedica (NYSE:ZOM)

Zomedica does not currently pay a dividend. Zomedica does not have a long track record of dividend growth.

Insiders buying/selling: Zomedica (NYSE:ZOM)

In the past three months, Zomedica insiders have not sold or bought any company stock. Only 4.40% of the stock of Zomedica is held by insiders. Only 4.42% of the stock of Zomedica is held by institutions.

Earnings and Valuation of Zomedica (NYSE:ZOM

Earnings for Zomedica are expected to grow in the coming year, from ($0.03) to ($0.02) per share. The P/E ratio of Zomedica is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Zomedica is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

More latest stories: here